Juvenile Idiopathic Arthritis Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: J81BBB5E4547EN
Market Monitor Global

Abstracts

Arthritis is a very common disease but it is not well understood yet. Arthritis is basically joint pain or joint disease. Basically Juvenile idiopathic arthritis or juvenile rheumatoid arthritis is the common inflammatory arthritis of childhood and Common symptom of Juvenile idiopathic arthritis is musculoskeletal pain. Juvenile idiopathic arthritis is mostly affected to under age 17 children.

This report contains market size and forecasts of Juvenile Idiopathic Arthritis Treatment in Global, including the following market information:

Global Juvenile Idiopathic Arthritis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Juvenile Idiopathic Arthritis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Juvenile Idiopathic Arthritis Treatment include Johnson & Johnson, Novartis, Bristol-Myers Squibb, Zydus Cadila, Takeda, Roche and Latona Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Juvenile Idiopathic Arthritis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Juvenile Idiopathic Arthritis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Juvenile Idiopathic Arthritis Treatment Market Segment Percentages, by Type, 2021 (%)

• Surgical Treatment
• Drug Treatment

Global Juvenile Idiopathic Arthritis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Juvenile Idiopathic Arthritis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Diagnostic Laboratories

Global Juvenile Idiopathic Arthritis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Juvenile Idiopathic Arthritis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Juvenile Idiopathic Arthritis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Juvenile Idiopathic Arthritis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Novartis
• Bristol-Myers Squibb
• Zydus Cadila
• Takeda
• Roche
• Latona Life Sciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Juvenile Idiopathic Arthritis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Juvenile Idiopathic Arthritis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL JUVENILE IDIOPATHIC ARTHRITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Juvenile Idiopathic Arthritis Treatment Market Size: 2021 VS 2028
2.2 Global Juvenile Idiopathic Arthritis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Juvenile Idiopathic Arthritis Treatment Players in Global Market
3.2 Top Global Juvenile Idiopathic Arthritis Treatment Companies Ranked by Revenue
3.3 Global Juvenile Idiopathic Arthritis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Juvenile Idiopathic Arthritis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Juvenile Idiopathic Arthritis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Juvenile Idiopathic Arthritis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Juvenile Idiopathic Arthritis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Juvenile Idiopathic Arthritis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Juvenile Idiopathic Arthritis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Surgical Treatment
  4.1.3 Drug Treatment
4.2 By Type - Global Juvenile Idiopathic Arthritis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Juvenile Idiopathic Arthritis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Juvenile Idiopathic Arthritis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Diagnostic Laboratories
5.2 By Application - Global Juvenile Idiopathic Arthritis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Juvenile Idiopathic Arthritis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Juvenile Idiopathic Arthritis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Juvenile Idiopathic Arthritis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Juvenile Idiopathic Arthritis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2028
  6.3.2 US Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.3.3 Canada Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.3.4 Mexico Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2028
  6.4.2 Germany Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.4.3 France Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.4.4 U.K. Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.4.5 Italy Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.4.6 Russia Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.4.8 Benelux Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2028
  6.5.2 China Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.5.3 Japan Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.5.4 South Korea Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.5.6 India Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2028
  6.6.2 Brazil Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.6.3 Argentina Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2028
  6.7.2 Turkey Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.7.3 Israel Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028
  6.7.5 UAE Juvenile Idiopathic Arthritis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Juvenile Idiopathic Arthritis Treatment Major Product Offerings
  7.1.4 Johnson & Johnson Juvenile Idiopathic Arthritis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Juvenile Idiopathic Arthritis Treatment Major Product Offerings
  7.2.4 Novartis Juvenile Idiopathic Arthritis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Juvenile Idiopathic Arthritis Treatment Major Product Offerings
  7.3.4 Bristol-Myers Squibb Juvenile Idiopathic Arthritis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Zydus Cadila
  7.4.1 Zydus Cadila Corporate Summary
  7.4.2 Zydus Cadila Business Overview
  7.4.3 Zydus Cadila Juvenile Idiopathic Arthritis Treatment Major Product Offerings
  7.4.4 Zydus Cadila Juvenile Idiopathic Arthritis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Zydus Cadila Key News
7.5 Takeda
  7.5.1 Takeda Corporate Summary
  7.5.2 Takeda Business Overview
  7.5.3 Takeda Juvenile Idiopathic Arthritis Treatment Major Product Offerings
  7.5.4 Takeda Juvenile Idiopathic Arthritis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Takeda Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Juvenile Idiopathic Arthritis Treatment Major Product Offerings
  7.6.4 Roche Juvenile Idiopathic Arthritis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Roche Key News
7.7 Latona Life Sciences
  7.7.1 Latona Life Sciences Corporate Summary
  7.7.2 Latona Life Sciences Business Overview
  7.7.3 Latona Life Sciences Juvenile Idiopathic Arthritis Treatment Major Product Offerings
  7.7.4 Latona Life Sciences Juvenile Idiopathic Arthritis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Latona Life Sciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Juvenile Idiopathic Arthritis Treatment Market Opportunities & Trends in Global Market
Table 2. Juvenile Idiopathic Arthritis Treatment Market Drivers in Global Market
Table 3. Juvenile Idiopathic Arthritis Treatment Market Restraints in Global Market
Table 4. Key Players of Juvenile Idiopathic Arthritis Treatment in Global Market
Table 5. Top Juvenile Idiopathic Arthritis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Juvenile Idiopathic Arthritis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Juvenile Idiopathic Arthritis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Juvenile Idiopathic Arthritis Treatment Product Type
Table 9. List of Global Tier 1 Juvenile Idiopathic Arthritis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Juvenile Idiopathic Arthritis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Juvenile Idiopathic Arthritis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Juvenile Idiopathic Arthritis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Juvenile Idiopathic Arthritis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Juvenile Idiopathic Arthritis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Juvenile Idiopathic Arthritis Treatment Product Offerings
Table 32. Johnson & Johnson Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Juvenile Idiopathic Arthritis Treatment Product Offerings
Table 35. Novartis Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Juvenile Idiopathic Arthritis Treatment Product Offerings
Table 38. Bristol-Myers Squibb Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Zydus Cadila Corporate Summary
Table 40. Zydus Cadila Juvenile Idiopathic Arthritis Treatment Product Offerings
Table 41. Zydus Cadila Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Takeda Corporate Summary
Table 43. Takeda Juvenile Idiopathic Arthritis Treatment Product Offerings
Table 44. Takeda Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Roche Corporate Summary
Table 46. Roche Juvenile Idiopathic Arthritis Treatment Product Offerings
Table 47. Roche Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Latona Life Sciences Corporate Summary
Table 49. Latona Life Sciences Juvenile Idiopathic Arthritis Treatment Product Offerings
Table 50. Latona Life Sciences Juvenile Idiopathic Arthritis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Juvenile Idiopathic Arthritis Treatment Segment by Type in 2021
Figure 2. Juvenile Idiopathic Arthritis Treatment Segment by Application in 2021
Figure 3. Global Juvenile Idiopathic Arthritis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Juvenile Idiopathic Arthritis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Juvenile Idiopathic Arthritis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Juvenile Idiopathic Arthritis Treatment Revenue in 2021
Figure 8. By Type - Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
Figure 12. US Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
Figure 24. China Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Juvenile Idiopathic Arthritis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Juvenile Idiopathic Arthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Juvenile Idiopathic Arthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Juvenile Idiopathic Arthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Juvenile Idiopathic Arthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Zydus Cadila Juvenile Idiopathic Arthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda Juvenile Idiopathic Arthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Juvenile Idiopathic Arthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Latona Life Sciences Juvenile Idiopathic Arthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)